Researchers found that CD163 SNPs exhibited significant correlations with classical Hodgkin’s lymphoma (CHL) and may be a predictive biomarkers for CHL prognosis (33), suggesting an important role for CD163 SNPs in predicting the prognosis of hematological tumors. Here, CD163 is linked to classic Hodgkin lymphoma.